New drug candidate reverses obesity in mice by transforming liver metabolism

FHS
May 2, 2024
3:11 am

A mitochondrial transcription inhibitor (IMT) shifted metabolism in high-fat diet mice toward fatty acid oxidation, leading to weight loss, reduced liver fat, and improved glucose tolerance.

GSK wins appeal to only pay AstraZeneca royalties on some sales of cancer drug Zejula

A panel of judges on the UK civil court of appeals agreed that GSK subsidiary Tesaro doesn’t have to pay royalties to AstraZeneca on total

February 16, 2024

Bristol Myers to cut 108 employees in New Jersey

Bristol Myers Squibb plans to let go of 108 employees in New Jersey, citing an “evolving” business model. The layoffs, set to go into effect

August 16, 2023

Philips failed to report corrections of CT machines, FDA says in warning letter

Dive Brief: The Food and Drug Administration identified problems with a Royal Philips facility that makes computed tomography (CT) and ultrasonography systems, the agency said

April 25, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.